维普期刊资源整合服务平台（V6.5）

22篇 您的检索式：作者名="Hart RK"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE study 显示文摘	Hochster HS Hart LL Ramanathan RK	2008	J Clin Oncol2008，26，21：	1
2	Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastat- ic colorectal cancer: results of the TREE study显示文摘	Hochster HS Hart LL Ramanathan RK	2008	J Clin On- col2008，26，21：	1
3	Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer:results of the TREE Study显示文摘	Hochster HS Hart LL Ramanathan RK		0，，21：	1
4	Sessile serrated adenomas strongly predispose to synchronous serrated polyps in non-syndromic patients显示文摘	Pai RK Hart J Noffsinger AE	2010	Histopathology2010，56，5：	1
5	Safety and efficacy of oxaliplatin/fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer (mCRC) : Final analysis of the TREE-Study 显示文摘	Hochster HS Hart LL Ramanathan RK	2006	Proc Am Soc Clin Oncol2006，24，18：	1
6	Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer:results of the TREE Study显示文摘	Hochster HS Hart LL Ramanathan RK	2008	J Clin Oncol2008，26，21：	1
7	Safety and efficacy of oxaliplatin/fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer( mCRC ) : Final analysis of the TREE-Study ( abstract3510 ) 显示文摘	Hochster HS Hart LL Ramanathan RK	2006	J Clin Oncol2006，24，18：	1
8	Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE Study显示文摘	Hoehster HS Hart LL Ramanathan RK	2008	J Clin Oncol2008，26，21：	1
9	Syatematic and Fully Automated Identification of Protein Sequence Patterns显示文摘	Hart RK Royyuru AK Stolovitzky G Califano A	2000	J Comp Biol2000，7，34：	1
10	Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE Study 显示文摘	Hochster HS Hart LL Ramanathan RK	2008	J Clin Oncol2008，26，21：	1
11	Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer:results of the TREE Study显示文摘	Hochster HS Hart LL Ramanathan RK	2008	J Clin Oncol2008，13，21：	1
12	Safety and effi- cacy of oxaliplatin and fluoropyrimidine regimens with or with- out bevacizumab as first-line treatment of metastatic colorectal cancer: resuhs of the TREE study 显示文摘	Hochster HS Hart LL Ramanathan RK	2008	J Clin Oncol2008，26，21：	1
13	Safety and efficacy of oxaliplatin/fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer (mCRC): Final analysis of the TREE Study显示文摘	Hochster HS Hart LL Ramanathan RK	2006	J Clin Oncol2006，24，21：	1
14	Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer:results of the TREE study显示文摘	Hochster HS Hart LL Ramanathan RK		Journal of Clinical Oncology0，，：	1
15	Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer:results of the TREE Study显示文摘	Hochster HS Hart LL Ramanathan RK	2008	J Clin Oncol2008，26，21：	1
16	The acute respiratory distress syndrome: from mechanism to translation显示文摘	Hart S Mallampalli RK	2015	J Immunol2015，194，3：	1
17	Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE Study显示文摘	Hochster HS Hart LL Ramanalhan RK	2008	J Clin Oncol2008，26，21：	1
18	Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE Study 显示文摘	Hochster HS Hart LL Ramanathan RK	2008	J Clin Oncol2008，26，21：	1
19	Safety and effi- cacy of oxaliplatin/flnoropyrimidine regimens with or without bevacizumab as first--line treatment of metastatic colorectal cancer (mCRC): final analysis ofthe TREE-study(abst)显示文摘	Hochster HS Hart LL Ramanathan RK	2006	Proc Am Soc Clin Oncol2006，24，18：	1
20	Safety and efficacy of oxalip latin / fluoropyrimidine regimens with or without bevacizumab asfirstline treatment of metastatic colorectal cancer (mCRC) : final a- nalysis of the TREE- study (abst) 显示文摘	Hochster HS Hart LL Ramanathan RK	2006	Proc Am Soc Clin Oncol2006，24，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示